CooperVision Creates Specialty Unit and Names Juan Carlos Aragon as its President

By


PLEASANTON, Calif.—CooperVision, Inc. has established a Specialty Eye Care business unit that is designed to accelerate eyecare professionals’ access to innovative products, according to an announcement Tuesday. Dr. Juan Carlos Aragon has been named president of the business, effectively immediately. The new Specialty Eye Care business encompasses Soflex, Procornea and Paragon Vision Sciences, which design and manufacture highly-specialized contact lenses for the management of myopia and other indications, the announcement noted. These organizations will continue to operate independently, yet share technical, clinical and commercial knowledge while benefiting from CooperVision’s global presence and infrastructure.

Dr. Aragon has three decades of experience in general management, professional services, sales, marketing and business development, according to the announcement. Since joining CooperVision in 2000, he has held senior roles in the Americas, Europe and Asia Pacific. Most recently, he was responsible for overseeing the company’s Southern and Central European commercial operations. He previously served in leadership positions with Ocular Sciences, CIBA Vision and Bausch + Lomb.

“The extensive management and contact lenses technical experience that Juan Carlos brings to the role will be essential to developing even stronger partnerships and opportunities for customers worldwide,” said Andrew Sedgwick, executive vice president, CooperVision. “He and his team will help expand the availability and adoption of advanced specialty products, complementing the wide-range of innovative contact lenses developed by CooperVision.”

Dr. Aragon graduated as an optometrist from the Superior School of Medicine of the National Polytechnic Institute in Mexico City. In addition to his professional responsibilities, he volunteers as chairman of Optometry Giving Sight and serves as a trustee of the International Agency for the Prevention of Blindness and Vision Aid Overseas.